J. Pers. Med. 2018, 8(4), 36; https://doi.org/10.3390/jpm8040036
Impact of Precision Medicine on Drug Repositioning and Pricing: A Too Small to Thrive Crisis
1
Department of Biological Sciences, Tennessee State University, 3500 John A Merritt Blvd, Nashville, TN 37209, USA
2
Department of Pharmacology, Vanderbilt University, Nashville, TN 37235, USA
Received: 29 October 2018 / Accepted: 31 October 2018 / Published: 5 November 2018
Abstract
The pricing of targeted medicines continues to be a major area of contention in healthcare economics. This issue is further complicated by redefining the role of molecular testing in precision medicine. Currently, whilst pricing of clinical laboratory diagnostics is cost-based, drug pricing is value-based. The pricing for molecular testing is under pressure to change the traditional business model, for it has a critical subsidiary role in determining the final value of targeted medicines. The market size for drugs is reduced by molecular testing when patients with the same disease are stratified based on their genetics, it is critical to determine the value of this new enhanced drug specificity to realize its full pricing potential. However, these value-based pricing strategies require a careful understanding of changing market conditions, especially, in the context of stratified patient segments made possible by precision medicine. In this article, we discuss the various factors impacting pricing decisions, and consider evolving economic trends in precision medicine. View Full-TextKeywords:
precision medicine; value-based pricing; drug repositioning; differential value; cost efficiency; healthcare
▼
Figures
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article
MDPI and ACS Style
Tiriveedhi, V. Impact of Precision Medicine on Drug Repositioning and Pricing: A Too Small to Thrive Crisis. J. Pers. Med. 2018, 8, 36.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
Related Articles
Article Metrics
Comments
[Return to top]
J. Pers. Med.
EISSN 2075-4426
Published by MDPI AG, Basel, Switzerland
RSS
E-Mail Table of Contents Alert